FDA全球物质注册数据库（FDA Global Substance Registration System）
物质名称METHYLNALTREXONE
异名/同义词(5.ALPHA.)-17-(CYCLOPROPYLMETHYL)-3,14-DIHYDROXY-17-METHYL-4,5-EPOXYMORPHINAN-17-IUM-6-ONE
METHYLNALTREXONE
METHYLNALTREXONE [MI]
METHYLNALTREXONE [VANDF]
METHYLNALTREXONE [WHO-DD]
METHYLNALTREXONE CATION
METHYLNALTREXONE ION
MNTX
MORPHINAN-17-IUM-6-ONE, 17-(CYCLOPROPYLMETHYL)-4,5-EPOXY-3,14-DIHYDROXY-17-METHYL-, (5.ALPHA.)-
MORPHINAN-17-IUM-6-ONE, 17-(CYCLOPROPYLMETHYL)-4,5-EPOXY-3,14-DIHYDROXY-17-METHYL-, (5.ALPHA.,17R)-
MORPHINANIUM, 17-(CYCLOPROPYLMETHYL)-4,5-EPOXY-3,14-DIHYDROXY-17-METHYL-6-OXO-, (5.ALPHA.)-
MRZ-2663
CAS登记号916055-93-1
物质唯一标识(Unique Ingredient Identifier)0RK7M7IABE
分子式C21H26NO4
国际化合物标识(International Chemical Identifier,InChI)JVLBPIPGETUEET-WIXLDOGYSA-O
SMILES[C@]123[C@@]4([C@]([H])([N@+](CC1)(CC5CC5)C)Cc6c2c(c(O)cc6)O[C@]3(C(CC4)=O)[H])O
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 美国国家药品档案
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System